(Q54350345)

28 May 2018

title

Catechol-O-methyltransferase genotype (Val158met) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors. (English)

1 reference

28 May 2018

César Fernández-de-las-Peñas

author

1

1 reference

28 May 2018

Manuel Arroyo-Morales

7

1 reference

28 May 2018

Irene Cantarero-Villanueva

3

Irene Cantarero-Villanueva

1 reference

28 May 2018

Carolina Fernández-Lao

2

Carolina Fernández-Lao

1 reference

28 May 2018

Silvia Ambite-Quesada

4

Silvia Ambite-Quesada

1 reference

28 May 2018

Inés Rivas-Martínez

5

Inés Rivas-Martínez

1 reference

28 May 2018

Rosario Del Moral-Avila

6

Rosario del Moral-Avila

1 reference

28 May 2018

language of work or name

English

0 references

publication date

4 September 2011

1 reference

28 May 2018

Breast Cancer Research and Treatment

published in

1 reference

28 May 2018

volume

133

1 reference

28 May 2018

issue

2

1 reference

28 May 2018

page(s)

405-412

1 reference

28 May 2018

https://scigraph.springernature.com/pub.10.1007/s10549-011-1757-y

exact match

0 references

cites work

Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

Retinotopic activation in response to subjective contours in primary visual cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

Cognitive functioning in breast cancer survivors: a controlled comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

Psychophysical examination in patients with post-mastectomy pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

Genetic Contribution of Catechol-O-methyltransferase Polymorphism in Patients with Migraine without Aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

Vagal modulation of nociception is mediated by adrenomedullary epinephrine in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

Genetic variation and response to morphine in cancer patients: catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

The role of cytokines in cancer-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

Inflammatory biomarkers for persistent fatigue in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

Immune-to-central nervous system communication and its role in modulating pain and cognition: Implications for cancer and cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

The Path to Personalized Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

Molecular epidemiology, cancer-related symptoms, and cytokines pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1757-Y

10.1007/S10549-011-1757-Y

21 January 2018

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018